Defining the Role of Nurses in Gene Therapy for Haemophilia
Haemophilia · 2026-07 · 32 (4) · 982-988
DOI: 10.1111/hae.70317 ↗Kurz gefasst
Fachartikel in der Zeitschrift Haemophilia, online erschienen am 21.05.2026. Verfasst von Greta Mulders und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Erasmus University Medical Center, Rotterdam, the Netherlands. Hauptthemen laut MEDLINE: Genetic Therapy, Hemophilia A, Hemophilia B, Nurse's Role. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Introduction
Haemophilia is a rare bleeding disorder now undergoing a major shift in care as gene therapy (GT), delivered through viral‑vector in vivo gene transfer, has enabled adults with haemophilia A or B to stop prophylaxis with minimal bleeding. As this treatment becomes a standard option in several European countries, nurses play an essential role in education, multidisciplinary care coordination, bleed management, and long‑term follow‑up, requiring ongoing professional development and potentially new specialist roles.
Aim
To describe and explore the multifaceted responsibilities of nurses throughout the GT pathway, emphasising their critical role in delivering holistic, patient‐centered care.
Method
This manuscript draws on discussions among experienced European haemophilia nurses to examine their expanding responsibilities throughout the GT pathways.
Results
Nurses play a central role throughout the GT pathway in haemophilia, guiding shared decision‑making, preparing patients for infusion, delivering safe peri‑infusion care, and coordinating extensive post‑infusion monitoring. Their responsibilities include eligibility assessment, patient education, vigilant observation during infusion, early detection of adverse events, and long‑term follow‑up of liver function, factor levels, and treatment durability. They also support psychosocial adjustment, provide lifestyle counselling, uphold ethical communication about uncertainties, and ensure continuity of care across hub‑and‑spoke networks. In addition, nurses contribute to registries, quality improvement, and research, generating real‑world evidence essential for evaluating long‑term safety and effectiveness of GT.
Conclusion
GT in haemophilia requires well‑trained and well‑informed nurses to ensure safe delivery, effective follow‑up, and high‑quality patient support throughout the entire treatment pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hematology, Erasmus University Medical Center, Rotterdam, the Netherlands.
- University of Oxford, Oxford, UK.
- Department of Hematology, Frankfurt University Hospital, Frankfurt, Germany.
- A. Bianchi Bonomi Hemophilia and Thrombosis Center, IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, Italy.
- Department of Hematology, Amsterdam Medical Center, Amsterdam, the Netherlands.
- Haemnet, London, UK.
Zitieren
APA
Mulders, G., Fletcher, S., Tasgin, A., Moro, M., Beijlevelt, M., & Khair, K. (2026). Defining the Role of Nurses in Gene Therapy for Haemophilia. Haemophilia, 32(4), 982-988. https://doi.org/10.1111/hae.70317
Vancouver
Mulders G, Fletcher S, Tasgin A, Moro M, Beijlevelt M, Khair K. Defining the Role of Nurses in Gene Therapy for Haemophilia. Haemophilia. 2026;32(4):982-988. doi:10.1111/hae.70317
BibTeX
@article{Mulders2026,
author = {Mulders, Greta and Fletcher, Simon and Tasgin, Aysen and Moro, Marica and Beijlevelt, Marléne and Khair, Kate},
title = {Defining the Role of Nurses in Gene Therapy for Haemophilia},
journal = {Haemophilia},
year = {2026},
volume = {32},
number = {4},
pages = {982--988},
doi = {10.1111/hae.70317}
}
EUVIMED